Circulating monocytes and tumor-associated macrophages express recombined immunoglobulins in glioblastoma patients
Abstract Background Glioblastoma is the most common and malignant brain tumor in adults. Glioblastoma is usually fatal 12–15 months after diagnosis and the current possibilities in therapy are mostly only palliative. Therefore, new forms of diagnosis and therapy are urgently needed. Since tumor-asso...
Main Authors: | Svenja Busch, Marina Talamini, Steffen Brenner, Amr Abdulazim, Daniel Hänggi, Michael Neumaier, Marcel Seiz-Rosenhagen, Tina Fuchs |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40169-019-0235-8 |
Similar Items
-
Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies
by: Matías Daniel Caverzán, et al.
Published: (2023-03-01) -
Systemic Reprogramming of Monocytes in Cancer
by: Máté Kiss, et al.
Published: (2020-09-01) -
Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells
by: Philippe Aretz, et al.
Published: (2022-04-01) -
Monocarboxylate Transporter 4 Regulates Glioblastoma Motility and Monocyte Binding Ability
by: Sheng-Wei Lai, et al.
Published: (2020-02-01) -
The Endless Saga of Monocyte Diversity
by: Stefania Canè, et al.
Published: (2019-08-01)